Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bosutinib in ADPKD
NCT01233869Phase 2Completed
- Sponsor
- Pfizer
- Start
- Dec 2010
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 17
01
Overview
A Phase 2 trial of bosutinib in autosomal dominant polycystic kidney disease (ADPKD), sponsored by Pfizer. Started Dec 2010; status: completed.
02
Drugs
bosutinib
03
Conditions
autosomal dominant polycystic kidney disease (ADPKD)
Beyond the preview
Go deeper on NCT01233869.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01233869.